Stock listing

OTC:MBXBF Microbix Biosystems Inc. Stock

US listing (OTC) of Microbix Biosystems Inc. · home listing TSX:MBX

Follow Microbix Biosystems Inc. into a list and get an email when it puts out news.

Share price · OTC:MBXBF

$0.192 USD -0.014 (-6.8%)

Close on Nov 20, 2026

Past year +26.9% · daily closes, Nov 20, 2025 – Nov 6, 2026, adjusted for splits
Day range
$0.192 – $0.192 USDNov 20, 2026
Volume
10,000 sharesNov 20, 2026
Market cap
$26.28M USDAt the close on Nov 20, 2026 · price × 137.0M shares outstanding
52-week range
$0.154 – $0.232 USDLowest and highest trades, Nov 21, 2025 – Nov 20, 2026
Traded on an average day
$631 USDMedian day 0 shares · 40 days with no trades · last 3 months, Aug 20, 2026 – Nov 6, 2026
Microbix Biosystems Inc. logo

Prices by listing

ListingLastChangeVolumeOpenHighLowPrevious closePrice from
TSX:MBX · Home$0.275 CAD0.000 (0.0%)27,858$0.295$0.295$0.275$0.275Close on Nov 20, 2026
OTC:MBXBF$0.192 USD-0.014 (-6.8%)10,000$0.192$0.192$0.192$0.206Close on Nov 20, 2026

Daily closes

Last 3 months, Aug 20, 2026 – Nov 6, 2026 · OTC:MBXBF · USD, adjusted for splits

DayCloseChange%OpenHighLowVolume
$0.217+0.002+0.9%$0.225$0.225$0.21430,000
$0.215-0.002-0.9%$0.215$0.215$0.2155,000
$0.2170.0000.0%$0.217$0.217$0.2170
$0.2170.0000.0%$0.217$0.217$0.2170
$0.217+0.009+4.3%$0.217$0.217$0.2175,000
$0.208-0.012-5.5%$0.208$0.208$0.2083,300
$0.2200.0000.0%$0.220$0.220$0.2200
$0.2200.0000.0%$0.220$0.220$0.2200
$0.220-0.010-4.3%$0.220$0.220$0.2203,000
$0.2300.0000.0%$0.230$0.230$0.2300
$0.2300.0000.0%$0.230$0.230$0.2300
$0.2300.0000.0%$0.230$0.230$0.2300
$0.230+0.007+3.1%$0.230$0.230$0.23030,000
$0.2230.0000.0%$0.223$0.223$0.2230
$0.223+0.008+3.7%$0.220$0.223$0.22035,000
$0.2150.0000.0%$0.215$0.215$0.2150
$0.2150.0000.0%$0.215$0.215$0.2150
$0.2150.0000.0%$0.215$0.215$0.2150
$0.2150.0000.0%$0.215$0.215$0.2150
$0.2150.0000.0%$0.215$0.215$0.2150
$0.2150.0000.0%$0.215$0.215$0.2150
$0.2150.0000.0%$0.215$0.215$0.2150
$0.215-0.008-3.6%$0.215$0.215$0.2151,000
$0.2230.0000.0%$0.223$0.223$0.2230
$0.2230.0000.0%$0.223$0.223$0.2230
$0.2230.0000.0%$0.223$0.223$0.2230
$0.2230.0000.0%$0.223$0.223$0.2230
$0.2230.0000.0%$0.223$0.223$0.2230
$0.223+0.006+2.8%$0.223$0.223$0.22318,400
$0.2170.0000.0%$0.217$0.217$0.2170
$0.2170.0000.0%$0.217$0.217$0.2170
$0.2170.0000.0%$0.217$0.217$0.2170
$0.217-0.001-0.5%$0.217$0.217$0.217100
$0.2180.0000.0%$0.218$0.218$0.21810,000
$0.2180.0000.0%$0.218$0.218$0.2180
$0.2180.0000.0%$0.218$0.218$0.2180
$0.218+0.001+0.5%$0.218$0.218$0.218500
$0.2170.0000.0%$0.217$0.217$0.2170
$0.2170.0000.0%$0.217$0.217$0.2170
$0.2170.0000.0%$0.217$0.217$0.2170
$0.217+0.003+1.4%$0.217$0.217$0.21710,000
$0.214-0.003-1.4%$0.215$0.215$0.2128,000
$0.2170.0000.0%$0.217$0.217$0.2170
$0.2170.0000.0%$0.217$0.217$0.2170
$0.2170.0000.0%$0.217$0.217$0.2170
$0.2170.0000.0%$0.217$0.217$0.217300
$0.2170.0000.0%$0.217$0.217$0.2170
$0.2170.0000.0%$0.217$0.217$0.2170
$0.2170.0000.0%$0.217$0.217$0.2170
$0.2170.0000.0%$0.217$0.217$0.217300
$0.2170.0000.0%$0.217$0.217$0.2170
$0.2170.0000.0%$0.217$0.217$0.2170
$0.2170.0000.0%$0.217$0.217$0.2170
$0.2170.0000.0%$0.217$0.217$0.2170
$0.2170.0000.0%$0.217$0.217$0.2170
$0.2170.0000.0%$0.217$0.217$0.2170
Ticker
OTC:MBXBF
Asset type
Stock
Sector
Health care
Industry
Diagnostics & research services
Exchange
OTC
Currency
USD

What changed lately

Latest news

All Microbix Biosystems Inc. news

Microbix Biosystems Inc. on 6ix

Sector
Health care
Industry
Diagnostics & research services
News releases
29 in the last 12 months · 199 in all · newest Nov 19, 2026 · oldest 2005
Calls
12 calls with a replay · 12 with a transcript · latest Aug 13, 2026
Decks
11 decks · latest Nov 17, 2026

Where Microbix Biosystems Inc. is listed

ListingExchangeCountryCurrency
TSX:MBX · Home listingTSXCanadaCAD
OTC:MBXBF · This pageOTCUnited StatesUSD
Cboe Canada:MBXCboe CanadaCanadaCAD

Cash and shares

Jun 30, 2026 · Microbix Biosystems — Investor Presentation (November 2026)

Shares outstanding
137.2 million

The slide these figures come from

Valuation

EV/sales 2.4× against a median of 1.8×: 6th lowest of 10 Diagnostics & research services companies shown. Statements: 4 quarters to Jun 30, 2026 · price Nov 20, 2026

Enterprise value
$37.23M CAD
P/E
Loss
EV/sales
2.4×
EV/EBITDA
Negative EBITDA
Price/book
1.6×
Gross margin
45.9%
Operating margin
−27.7%
Net margin
−31.7%
Debt to equity
0.3×
Beta vs S&P/TSX Composite
0.03

Diagnostics & research services: the 10 companies nearest in size, of 302 on 6ix with figures. Size in US dollars.

CompanyMkt capEVP/EEV/SalesEV/EBITDAP/BNet mgnDebt/EqBeta
Microbix Biosystems Inc. · TSX:MBXUS$26.27MUS$25.96Mn/a2.4×n/a1.6×−31.7%0.3×0.03
Abingdon Health PLC · LSE:ABDXUS$28.10MUS$26.11Mn/a1.8×n/a3.5×−19.4%0.2×n/a
MedMira Inc. · TSXV:MIRUS$26.91MUS$27.23Mn/a105×n/an/a−808.2%n/a0.29
BIOQUAL, Inc. · OTC:BIOQUS$26.83MUS$42.28Mn/a1.1×n/a0.8×−11.0%1.0×-0.01
Ikonisys SA · EURONEXT:ALIKOUS$26.75MUS$31.11Mn/a20.4×n/a1.3×−302.8%0.3×n/a
Interpace Biosciences, Inc. · OTC:IDXGUS$26.56MUS$23.63M1.2×0.6×21.0×1.1×58.1%0.0×-0.33
Bioptic Inc. · TPEX:6850US$26.10MUS$22.55Mn/an/an/a2.0×n/a0.2×n/a
genOway SA · EURONEXT:ALGENUS$25.86MUS$38.95M25.4×1.7×8.7×1.1×4.4%0.7×n/a
Orientbio, Inc. · KRX:002630US$25.17M−US$3.29M14.6×−0.1×−0.8×0.5×8.1%0.0×n/a
Genesystem Co., Ltd. · KRX:363250US$24.68MUS$22.48Mn/a29.8×n/a2.8×n/a0.2×n/a
Clever Culture Systems Limited · ASX:CC5US$24.56MUS$25.41Mn/a8.3×n/a4.9×−48.4%0.4×n/a
Median of the othersUS$26.33MUS$25.76M14.6×1.8×8.7×1.3×−15.2%0.2×-0.01

Forecasts

Analysts' consensus from EODHD, read Nov 20, 2026. Not 6ix's view and not investment advice.

Price target
0.40 CAD · Analysts' mean
EPS, year to Sep 2026
-0.010 · 1 analyst
Revenue, year to Sep 2026
11.55M · 1 analyst

Team and board

Officers

OfficerRole
Cameron GroomeCEO, PRESIDENT AND DIRECTOR
Jim CurrieCFO
Ken HughesCOO
Deborah HonigInvestor Relations
Mark LuscherSVP, SCIENTIFIC AFFAIRS
Phil CasselliSVP BUSINESS DEVELOPMENT, SALES AND MARKETING

Board

DirectorRole
Martin MarinoCHAIRMAN OF THE BOARD
Cameron GroomeCEO, PRESIDENT AND DIRECTOR
Jennifer StewartDIRECTOR
Mark A. CochranDIRECTOR
Peter M. BlecherDIRECTOR
Vaughn C. Embro-PantalonyDIRECTOR

Events

Next results
Dec 17, 2026 (expected)

Calls

CallWhenStatus
Microbix Biosystems (TSX:MBX) Q3 2026 Earnings CallThu, Aug 13, 2026 · 10:00 AM ETReplay
Microbix Biosystems (TSX:MBX) Q2 2026 Earnings CallThu, May 14, 2026 · 10:00 AM ETReplay
Microbix Biosystems (TSX:MBX) Q1 2026 Earnings CallThu, Feb 12, 2026 · 10:00 AM ETReplay
Microbix Biosystems (TSX:MBX) Q4 2025 Earnings CallThu, Dec 18, 2025 · 10:00 AM ETReplay
Microbix Biosystems (TSX:MBX) Q3 2025 Earnings CallThu, Aug 14, 2025 · 10:00 AM ETReplay
Microbix Biosystems (TSX:MBX) Q2 2025 Earnings CallThu, May 15, 2025 · 11:00 AM ETReplay
Microbix Biosystems (TSX:MBX) Q1 2025 Earnings CallThu, Feb 13, 2025 · 11:00 AM ETReplay
Microbix Biosystems (TSX:MBX) Q4 2024 Earnings CallThu, Dec 19, 2024 · 11:00 AM ETReplay
Microbix Biosystems (TSX:MBX) Q3 2024 Earnings CallWed, Aug 14, 2024 · 10:00 AM ETReplay
Microbix Biosystems (TSX:MBX) Q2 2024 Earnings CallWed, May 15, 2024 · 10:00 AM ETReplay
All 12 calls
CallWhenStatus
Microbix Biosystems (TSX:MBX) Q4 2023 Earnings CallWed, Jan 03, 2024 · 11:00 AM ETReplay
Microbix Biosystems (TSX:MBX) Q3 2023 Earnings CallMon, Aug 14, 2023 · 11:00 AM ETReplay

Results days

QuarterResultsShare move
Q3 2026Aug 13, 2026 · Before open−6.3%
Q2 2026May 14, 2026 · Before open−9.8%
Q1 2026Feb 12, 2026 · Before open−2.2%
Q4 2025Dec 18, 2025 · Before open−12.5%
Q3 2025Aug 13, 2025 · Before open−1.8%
Q2 2025May 15, 2025 · Before open−5.6%
Q1 2025Feb 13, 2025 · Before open0.0%
Q4 2024Dec 19, 2024 · Before open+2.8%
Q3 2024Aug 14, 2024 · Before open+3.0%
Q2 2024May 15, 2024 · Before open+9.4%
All 20 quarters
QuarterResultsShare move
Q1 2024Feb 14, 2024 · Before open+6.3%
Q4 2023Dec 21, 2023 · Before open−6.7%
Q3 2023Aug 10, 2023 · Before open−3.1%
Q2 2023May 11, 2023 · Before open0.0%
Q1 2023Feb 9, 2023 · Before open−14.3%
Q4 2022Dec 22, 2022 · Before open−5.9%
Q3 2022Aug 11, 2022 · Before open+2.0%
Q2 2022May 12, 2022 · Before open−3.2%
Q1 2022Feb 10, 2022 · Before open+4.6%
Q4 2021Dec 23, 2021 · Before open+5.1%

Open Events

Decks

DeckKindSlidesDate
Investor Presentation (November 2026)Investor deck28 slidesNov 17, 2026
Investor Presentation (September 2026)Investor deck24 slidesSeptember 2026
Investor Presentation (August 2026)Investor deck24 slidesAug 18, 2026
Investor Presentation (September 2025)Investor deck21 slidesSep 23, 2025
Investor Presentation (August 2025)Investor deck21 slidesAugust 2025
Investor Presentation (May 2025)Investor deck21 slidesMay 15, 2025
Investor Presentation (May 2023)Investor deck23 slidesMay 12, 2023
Investor Presentation (November 2022)Investor deck24 slidesNov 25, 2022
Investor Presentation (September 2022)Investor deck24 slidesSep 19, 2022
Shareholder Meeting (March 2021)Shareholder meeting20 slidesMarch 2021
All 11 decks
DeckKindSlidesDate
Investor Presentation (May 2014)Investor deck22 slidesMay 2014

Open Decks

Financials

Annual, in CAD

Income statement

LineFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Revenue18.6M25.4M16.5M19.1M18.6M10.5M13.4M12.5M10.2M9.52M
Cost of revenue8.73M10.0M9.03M7.95M7.55M5.86M6.86M7.14M5.37M4.54M
Gross profit9.85M15.4M7.48M11.1M11.0M4.66M6.55M5.37M4.81M4.98M
Research and development2.33M2.13M2.05M1.80M1.03M1.01M1.04M1.09M994.6K493.6K
Selling, general and administrative8.76M8.63M6.53M5.00M4.22M3.54M3.74M3.61M3.93M3.13M
Operating income-1.58M3.91M-2.74M2.69M4.84M-524.6K1.11M-742.8K-1.50M148.4K
Depreciation and amortization1.78M1.61M1.16M1.04M822.0K690.1K568.8K690.1K510.2K413.7K
EBITDA203.2K5.52M-1.58M3.73M5.66M165.5K1.68M-52.7K-989.4K562.1K
Interest expense950.4K921.8K839.4K826.6K1.60M1.06M1.07M852.0K924.6K691.3K
Income before tax-2.30M3.67M-39.5K1.87M3.23M-4.66M43.7K-8.62M-4.23M148.4K
Income tax-55.7K150.6K839.4K77.2K1.60M1.57M11.8K-7.03M-450.0K-600.0K
Net income-2.25M3.52M-39.5K1.79M1.63M-6.23M31.9K-8.62M-3.78M748.4K
Earnings per share, basic-0.020.03-0.000.010.01-0.060.00-0.09-0.040.01

Balance sheet

LineFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Cash and equivalents12.1M13.0M11.6M13.5M9.99M92.7K95.6K44.4K54.5K5.42K
Receivables1.61M4.19M4.18M3.09M4.21M1.89M1.71M1.41M1.49M2.20M
Inventory9.20M6.46M5.75M5.28M4.41M4.29M4.48M4.45M4.47M3.40M
Current assets23.6M24.3M22.3M22.4M19.1M6.49M6.45M6.07M6.16M5.66M
Property, plant and equipment10.1M9.62M8.93M8.91M8.08M7.36M6.65M6.65M12.2M12.3M
Total assets37.4M38.1M35.7M33.1M28.8M15.6M19.6M19.3M26.4M25.2M
Accounts payable1.98M2.66M2.08M1.83M1.79M1.49M1.46M1.77M2.84M1.90M
Current liabilities2.78M3.39M4.35M2.65M5.19M4.09M4.77M4.16M6.52M5.25M
Long-term debt5.26M5.59M5.68M4.71M4.09M4.51M4.16M4.55M4.67M4.70M
Total debt6.77M6.40M6.65M5.82M7.74M6.17M6.99M6.26M7.28M7.37M
Total liabilities9.62M9.80M11.0M8.21M10.3M8.98M9.09M8.96M11.3M9.96M
Shareholders' equity27.8M28.3M24.6M24.9M18.6M6.62M10.5M10.4M15.2M15.3M
Shares outstanding139.2M137.5M137.9M141.7M141.7M104.8M97.1M96.2M85.0M84.7M

Cash flow

LineFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Cash from operations-80.3K4.35M-1.09M3.47M2.11M8.57K44.4K-537.0K297.0K913.3K
Capital spending-797.3K-1.91M-1.02M-2.03M-1.30M-813.9K-514.8K-1.22M-640.8K-1.64M
Free cash flow-877.6K2.44M-2.11M1.44M804.2K-805.3K-470.4K-1.76M-343.7K-727.8K
Cash from investing-797.3K-1.91M-1.02M-2.03M-622.3K-813.9K-514.8K-1.22M-640.8K-1.64M
Cash from financing27.0K-1.08M229.2K2.06M8.41M802.4K521.6K1.74M392.7K629.1K
Share buybacks-1.73M-925.3K-1.12M3.44M8.33M2.15M03.24M0531.7K
Change in cash-850.6K1.36M-1.88M3.50M9.89M-2.91K51.2K-10.1K49.0K-98.8K

Open Financials

Cap table

Built by 6ix from Microbix Biosystems Inc.’s releases

Common shares
136,968,656
Fully diluted
136,968,656

Fully diluted

LineShares
Common shares136,968,656

Share count over time

CountShares
Nov 22, 2026136,968,656

Open Cap table

Shareholders

TradeTradeSharesPriceValueDate
Cameron L Groome
Director of Issuer
Buy29,500CAD 0.29CAD 8,703Sep 10, 2026
Cameron L Groome
Director of Issuer
Buy500CAD 0.29CAD 148Jul 23, 2026
Cameron L Groome
Director of Issuer
Buy12,000CAD 0.29CAD 3,540Jun 30, 2026
Cameron L Groome
Director of Issuer
Buy2,000CAD 0.29CAD 590Jun 17, 2026
Cameron L Groome
Director of Issuer
Buy1,000CAD 0.28CAD 275Jun 15, 2026
Daniel Oliveira Costa
Senior Officer of Issuer
Buy5,000CAD 0.28CAD 1,375Jun 15, 2026
Daniel Oliveira Costa
Senior Officer of Issuer
Buy6,000CAD 0.28CAD 1,710Jun 10, 2026
Daniel Oliveira Costa
Senior Officer of Issuer
Buy1,000CAD 0.27CAD 270Jun 8, 2026
Daniel Oliveira Costa
Senior Officer of Issuer
Buy1,000CAD 0.27CAD 270Jun 5, 2026
Daniel Oliveira Costa
Senior Officer of Issuer
Buy3,500CAD 0.27CAD 928Jun 4, 2026
All 23 trades
TradeTradeSharesPriceValueDate
Daniel Oliveira Costa
Senior Officer of Issuer
Buy1,500CAD 0.27CAD 398Jun 3, 2026
Daniel Oliveira Costa
Senior Officer of Issuer
Buy4,000CAD 0.27CAD 1,080Jun 2, 2026
Daniel Oliveira Costa
Senior Officer of Issuer
Buy4,500CAD 0.27CAD 1,193Jun 2, 2026
Daniel Oliveira Costa
Senior Officer of Issuer
Buy2,500CAD 0.27CAD 663May 29, 2026
Martin Marino
Director of Issuer
Buy115,000CAD 0.28CAD 31,625May 28, 2026
Martin Marino
Director of Issuer
Buy24,500CAD 0.26CAD 6,370May 27, 2026
Martin Marino
Director of Issuer
Buy69,000CAD 0.26CAD 17,940May 26, 2026
Daniel Oliveira Costa
Senior Officer of Issuer
Buy500CAD 0.24CAD 120May 25, 2026
Daniel Oliveira Costa
Senior Officer of Issuer
Buy5,500CAD 0.25CAD 1,375May 22, 2026
Martin Marino
Director of Issuer
Buy30,000CAD 0.24CAD 7,200Jan 2, 2026
Martin Marino
Director of Issuer
Buy17,500CAD 0.24CAD 4,200Dec 30, 2025
Martin Marino
Director of Issuer
Buy52,500CAD 0.23CAD 12,338Dec 29, 2025
Martin Marino
Director of Issuer
Buy100,000CAD 0.23CAD 22,500Dec 22, 2025

Open Shareholders

People

6ix reads each seat by machine from the page it links to, and can misread one.

PersonSeat
Cameron GroomeCEO, PRESIDENT AND DIRECTOR · Since at least Nov 2, 2026
Deborah HonigInvestor Relations · Since at least Nov 2, 2026
Jennifer StewartDIRECTOR · Since at least Mar 26, 2026
Jim CurrieCFO · Since at least Nov 2, 2026
Joe RennerUntil Nov 2, 2026 · Past
Ken HughesCOO · Since at least Apr 16, 2026
Mark A. CochranDIRECTOR · Since at least Mar 26, 2026
Mark LuscherSVP, SCIENTIFIC AFFAIRS · Since at least Oct 8, 2026
Martin MarinoCHAIRMAN OF THE BOARD · Since at least Mar 26, 2026
Peter M. BlecherDIRECTOR · Since at least Mar 26, 2026
All 12 people
PersonSeat
Phil CasselliSVP BUSINESS DEVELOPMENT, SALES AND MARKETING · Since at least Dec 3, 2025
Vaughn C. Embro-PantalonyDIRECTOR · Since at least Mar 26, 2026

Open People

Log in to ask 6ix AI your own questions about Microbix Biosystems Inc.